BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/9/2024 8:41:19 AM | Browse: 79 | Download: 193
 |
Received |
|
2024-05-25 11:05 |
 |
Peer-Review Started |
|
2024-05-25 11:07 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-06-19 06:37 |
 |
Revised |
|
2024-06-29 04:04 |
 |
Second Decision |
|
2024-07-26 02:33 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-07-26 08:41 |
 |
Articles in Press |
|
2024-07-26 08:41 |
 |
Publication Fee Transferred |
|
2024-08-07 09:16 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-08-13 04:45 |
 |
Publish the Manuscript Online |
|
2024-09-09 08:41 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Biology |
Manuscript Type |
Basic Study |
Article Title |
Human bone marrow mesenchymal stem cell-derived exosomes loaded with gemcitabine inhibit pancreatic cancer cell proliferation by enhancing apoptosis
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Zu-Gui Tang, Tie-Mei Chen, Yi Lu, Zhe Wang, Xi-Cheng Wang and Yi Kong |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Guangdong Basic and Applied Basic Research Foundation |
2019A1515011609 |
Project of Educational Commission of Guangdong Province of China |
2018KQNCX124 |
Guangzhou Science and Technology Key Point Project |
202103000041 |
|
Corresponding Author |
Yi Kong, PhD, Associate Professor, Faculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, No. 1068 Xueyuan Avenue, Nanshan District, Shenzhen 518000, Guangdong Province, China. yi.kong@siat.ac.cn |
Key Words |
Mesenchymal stem cells; Exosomes; Extracellular vesicles; Gemcitabine; Pancreatic cancer; Drug delivery |
Core Tip |
This study investigates the utilization of exosomes derived from human bone marrow mesenchymal stem cells as a novel system to deliver gemcitabine (GEM) for the treatment of pancreatic cancer. Through the optimization of GEM loading into exosomes, the results indicate that exosomes loaded with GEM (Exo-GEM) have a potent cytotoxicity against pancreatic cancer cells by enhancing their apoptosis in vitro. These findings underscore the potential of Exo-GEM as a more efficient and targeted therapeutic approach for enhancing therapeutic efficacy in patients with pancreatic cancer. |
Publish Date |
2024-09-09 08:41 |
Citation |
<p>Tang ZG, Chen TM, Lu Y, Wang Z, Wang XC, Kong Y. Human bone marrow mesenchymal stem cell-derived exosomes loaded with gemcitabine inhibit pancreatic cancer cell proliferation by enhancing apoptosis. <i>World J Gastrointest Oncol</i> 2024; 16(9): 4006-4013</p> |
URL |
https://www.wjgnet.com/1948-5204/full/v16/i9/4006.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v16.i9.4006 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345